LEXICON PHARMACEUTICALS, INC.

$100m committed across 1 active facility, next covenant test Sep 30, 2026. LXRX

Pharmaceutical Preparations

Recent changes

  1. Aug 6, 2026LEXICON PHARMACEUTICALS, INC. signs $100m LOAN AND SECURITY AGREEMENTSEC ↗
Tested otherHeadroom not yet measuredn/a
Beginning on the Initial Minimum Cash Test Date and at all times thereafter, the Borrower shall maintain Qualified Cash in an amount greater than or equal to the aggregate amount of the Secured Obligations, multiplied by the Minimum Cash Coverage Percentage.
Read the filing on sec.gov ↗
Tested monthlyHeadroom not yet measuredn/a
Borrower shall either: (i) satisfy Performance Covenant C, to be tested as of the last day of each month after the Initial Performance Covenant Test Date;
Read the filing on sec.gov ↗
Tested otherHeadroom not yet measuredn/a
“Performance Covenant A” means Borrower maintains Qualified Cash, at all times, in an amount greater than or equal to [**] percent ([**]%) of the outstanding principal amount of the Secured Obligations.
Read the filing on sec.gov ↗
Tested otherHeadroom not yet measuredn/a
“Performance Covenant B” means (i) Borrower maintains Qualified Cash, at all times, in an amount greater than or equal to the outstanding principal amount of the Secured Obligations, multiplied by [**] percent ([**]%) and (ii) Company’s Market Capitalization, at all times, is greater than [**].
Read the filing on sec.gov ↗

Download CSV · Download JSON

No amendments on file yet.

Report an error